Japanese officials enter a Kobayashi Pharmaceutical factory to conduct an on-site inspection in Osaka City, on 30 March, 2024. Photo: AFP/ Mami Nagaoki
Previous
Analysis: Lando Norris win shows McLaren is ready to return to global motorsports prominence
Next
Chinese scientists create mutant Ebola virus to skirt around biosafety rules